share_log

Eli Lilly and Co | DEFA14A: Others

SEC announcement ·  Mar 23 04:29
Summary by Futu AI
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.